MétaCan
Menu
Back to cohort

Glucagon-like peptide 2: an update

2005· article· en· W2023894513 on OpenAlexaff
Eric D. Shin, Daniel J. Drucker, Patricia L. Brubaker

Bibliographic record

VenueCurrent Opinion in Endocrinology & Diabetes · 2005
Typearticle
Languageen
FieldNursing
TopicClinical Nutrition and Gastroenterology
Canadian institutionsDiabetes CanadaUniversity of Toronto
Fundersnot available
KeywordsGlucagon-like peptide-2Enteroendocrine cellGastrointestinal tractShort bowel syndromeAnabolismGlucagon-like peptide-1MedicineEndocrine systemBiologyInternal medicineEndocrinologyPeptideHormoneBiochemistryDiabetes mellitusParenteral nutrition

Abstract

fetched live from OpenAlex

Purpose of review Glucagon-like peptide 2 (GLP-2) is a 33-amino acid peptide secreted in a nutrient-dependent manner from gut enteroendocrine cells. The proliferative and antiapoptotic actions of GLP-2 lead to expansion of the mucosal surface area and enhanced capacity for nutrient absorption in multiple models of experimental intestinal injury. These findings have raised the possibility that GLP-2 administration may produce therapeutic benefit in humans with intestinal insufficiency. Recent findings The actions of GLP-2 appear restricted to the gastrointestinal tract, central nervous system, and skeleton. GLP-2 exerts its effects through a G-protein-coupled receptor expressed in enteric neurons or enteroendocrine cells, suggesting that many of its actions are likely indirect through as yet unidentified secondary mediators. Exogenous administration of GLP-2 to mice, rats, or pigs reduces morbidity associated with intestinal damage and improves the structure and function of the intestinal mucosa. GLP-2 also exerts anabolic actions in bone via prevention of resorption. GLP-2 may also act in the brain to enhance neuronal survival via direct antiapoptotic actions. The cytoprotective and proliferative actions of GLP-2 highlight the need for further information on the efficacy and safety of long-term administration of GLP-2 in human subjects. Summary The available evidence suggests that GLP-2 upregulates pathways promoting restoration of intestinal barrier and absorptive function, leading to reduced bacterial translocation, improved nutrient uptake, and enhanced energy absorption. Degradation-resistant GLP-2 analogues are currently being tested in human clinical trials of subjects with inflammatory bowel disease and short bowel syndrome. Hence, GLP-2 may ultimately be used as a therapeutic agent for the treatment of metabolic disorders characterized by insufficient nutrient absorption.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.762
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.045
GPT teacher head0.357
Teacher spread0.312 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2005
Admission routes1
Has abstractyes

Explore more

Same venueCurrent Opinion in Endocrinology & DiabetesSame topicClinical Nutrition and GastroenterologyFrench-language works237,207